Prolactin monitoring of haloperidol and pimozide treatment in children with Tourette's syndrome

Biological Psychiatry

Volumn 40, Issue 10, 1996, Pages 1044-1050

  Sallee, Floyd R ^a   Dougherty, Douglas ^a   Sethuraman, Gopalan ^a   Vrindavanam, Nandagopal ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

extrapyramidal symptoms; haloperidol; pimozide; prolactin; Tourette's syndrome

Indexed keywords

HALOPERIDOL; MARKER; PIMOZIDE; PROLACTIN;

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; EXTRAPYRAMIDAL SYMPTOM; GILLES DE LA TOURETTE SYNDROME; HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SCHOOL CHILD; TIC;

EID: 0030588958     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(95)00596-X     Document Type: Article

References (24)

1. Bruun RD (1988): Subtle and under recognized side effects of neuroleptic treatment in children with Tourette's disorder. Am J Psychiatry 145:621-628.
2. Campbell M, Adams P, Perry R, Spencer EK, Overall JE (1988): Tardive and withdrawal dyskinesia in autistic children: A prospective study. Psychopharmacol Bull 24:251-255.
3. Chouinard G, Annable L, Ross-Chouinard A, Kropsy ML (1979): Ethopropazine and benztropine in neuroleptic-induced parkinsonism. J Clin Psychiatry 40:73-81.
4. Collu R, Jequier JC, Leboeuf G, Letarte J, Ducharme JR (1975): Endocrine effects of pimozide, a specific dopaminergic blocker. J Clin Endocrinol Metab 41:981-4.
5. Evans LEJ, Beumont PJV, Luttrell B (1980): Prolactin response as a guide to neuroleptic treatment of schizophrenia. Prog Reprod Biol 6:260-263.
6. Guy W (1976): ECDEU Assessment Manual for Psychopharmacology. Washington, DC: US Department of Health, Education, and Welfare, pp 634-637.
7. Harcherik DF, Leckman JF, Detlor J, Cohen DJ (1984): A new instrument for clinical studies of Tourette's syndrome. J Am Acad Child Psychiatry 23:153-160.
8. Kirkpatrick B, Carpenter WT, Maeda K, Buchanan RW, Breier A, Tamminga CA (1992): Plasma prolactin as a predictor of relapse in drug-free schizophrenic outpatients. Biol Psychiatry 32:1049-1054.
9. Leckman JF, Knorr AM, Rasmusson AM, Cohen DJ (1991): Basal ganglia research and Tourette's syndrome. Trends in Neuroscience 14:94.
10. MacLeod RM (1976): Regulation of prolactin secretion. In Martini L, Ganong WF (eds), Frontiers in Neuroendocrinology. New York: Raven Press, pp. 169-194.
11. McEvoy J, Hogarty GE, Steingard S (1991a): Optimal dose of neuroleptic in acute schizophrenia. Arch Gen Psychiatry 48:739-745.
12. McEvoy JP, Schooler NR, Wilson WH (1991b): Predictors of therapeutic response to haloperidol in acute schizophrenia. Psychopharmacol Bull 27:97-101.
13. Meltzer HY, Busch DA, Fang VS (1983): Serum neuroleptic and prolactin levels in schizophrenic patients and clinical response. Psychiatry Res 9:271-283.
14. Newcomer JW, Riney SJ, Vinogradov S, Csernansky JG (1992): Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements after neuroleptic dose decrease. Psychopharmacol Bull 28:101-107.
15. Rao VAR, Bishop M, Coppen A (1980): Clinical state, plasma levels of haloperidol and prolactin: A correlation study in schizophrenia. Br J Psychiatry 137:518-521.
16. Richardson MA, Haugland G, Craig TJ (1991): Neuroleptic use, parkinsonian symptoms, tardive dyskinesia, and associated factors in child and adolescent psychiatric patients. Am J Psychiatry 148:1322-1328.
17. Rubin RT (1984): Prolactin and schizophrenia. In Meltzer HY (ed), Psychopharmacology: The Third Generation of Progress. New York: Raven Press, pp 803-808.
18. Silva RR, Magee HJ, Friedhoff AJ (1993): Persistent tardive dyskinesia and other neuroleptic-related dyskinesias in Tourette's disorder. J Child Adolesc Psychopharmacol 3:137-144.
19. Siris SG, van Kammen DP, De Fraites EG (1978): Serum prolactin and antipsychotic responses to pimozide in schizophrenia. Psychopharmacol Bull 14:11-14.
20. Swiger ME, Jatlow PI, Goicoechea N, Opsahl C, Bowers MB (1984): Ratio of serum prolactin to haloperidol and early clinical outcome in acute psychosis. Am J Psychiatry 141: 1281-1283.
21. Van Putten T, Marder SR, Mintz J (1991): Serum prolactin as a correlate of clinical response to haloperidol. J Clin Psychopharmacol 11:357-361.
22. Tecott LH, Kwong LL, Uhr S, Peroutka SJ (1986): Differential modulation of dopamine D2 receptors by chronic haloperidol, nitrendipine and pimozide. Biol Psychiatry 21:1114-1122.
23. Walkup JT, Rosenberg LA, Brown J, Singer H (1992): The validity of instruments measuring tic severity in Tourette's syndrome. J Am Acad Child Adolesc Psychiatry 31:472-477.
24. Walters JR, Roth RH (1975): Dopaminergic neurons: Alternations in the sensitivity of tyrosine hydroxylase to inhibition by endogenous dopamine after cessation of impulse flow. J PET 25:649-654.